United Therapeutics | UTHR - Operating Profit


United Therapeutics reported $-14.6M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Amarin USD -1.7M 8.47M Sep/2025
Ardelyx USD 4.67M 19.07M Sep/2025
Baxter International USD -214.2M 415.4M Dec/2025
Bayer EUR 1.11B 1.65B Dec/2025
BioCryst Pharmaceuticals USD -2.54M 10.23M Dec/2024
Biogen USD 659.6M 192.2M Sep/2025
BioMarin Pharmaceutical USD 198.39M 230.08M Dec/2025
Emergent BioSolutions USD -218M 69.9M Jun/2023
Esperion Therapeutics USD -16.03M 18.6M Sep/2024
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Halozyme Therapeutics USD -88.41M 306.33M Dec/2025
Insmed USD -249.71M 11.64M Dec/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
J&J USD 5.59B 1.81B Dec/2025
Lexicon Pharmaceuticals USD -55.35M 10.02M Jun/2024
Moderna USD -857M 597M Dec/2025
Omeros USD -35.41M 23.75M Sep/2024
Pfizer USD 4.65B 3.99B Dec/2025
PTC Therapeutics USD -81.62M 85.11M Dec/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Sangamo BioSciences USD -33.51M 12.77M Jun/2024
Sarepta Therapeutics USD -410.08M 347.2M Dec/2025
Teva Pharmaceutical Industries USD 487M 581M Dec/2025
United Therapeutics USD -14.6M 403.9M Dec/2025
Vertex Pharmaceuticals USD 1.26B 24.5M Dec/2025